• Cloud DX (CDX) announces a brokered private placement of convertible debenture units for gross proceeds of up to $3,000,000
  • The agents have an option to sell up to 450 additional convertible debenture units for maximum aggregate gross proceeds of $3,450,000
  • The company intends to use the net proceeds of the offering for sales, marketing, research and development
  • The offering is expected to close on or about September 23, 2021
  • Cloud DX Inc. (CDX) opened trading at C$0.23 per share

Cloud DX (CDX) has announced a brokered private placement of up to 3,000 convertible debenture units for gross proceeds of up to $3,000,000.

Echelon Wealth Partners Inc. has agreed to act as lead agent and sole book runner on behalf of a syndicate of investment dealers. The agents have an option to sell up to 450 additional convertible debenture units for maximum aggregate gross proceeds of $3,450,000.

Each debenture unit will consist of $1,000 principal amount unsecured convertible debenture and 1,430 common share purchase warrants. The debentures will mature 36 months from the date of issuance and shall bear interest at a rate of 10% per annum. Interest will be payable quarterly on the last business day of each quarter, commencing on December 31, 2021.

The company intends to use the net proceeds of the offering for sales, marketing, research and development, and for general working capital purposes.

The offering is expected to close on or about September 23, 2021.

Accelerating virtual healthcare’s future, Cloud DX is making healthcare better for everyone. The company’s Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable ageing in place and deliver hospital-quality post-surgical care.

Cloud DX Inc. (CDX) opened trading at C$0.23 per share.

More From The Market Online

Calian scores $23 million Canadian Armed Forces contract

Calian Group Ltd. (TSX:CGY) has been awarded a $17 million contract by the Canadian Armed Forces’ Canadian Forces Health Services Group.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

This life sciences company is gearing up to treat long COVID  

Revive Therapeutics (CSE:RVV), a Toronto-based company, has immense potential to capitalize on treating long COVID symptoms.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.